Literature DB >> 8691124

Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor coligation.

Y Yamashita1, K Miyake, Y Miura, Y Kaneko, H Yagita, T Suda, S Nagata, J Nomura, N Sakaguchi, M Kimoto.   

Abstract

Signals through the B cell antigen receptor lead to a variety of cellular events such as activation, anergy, and apoptosis. B cells select these outcomes to establish and maintain self-tolerance, and to mount adequate antibody responses. However, it is not fully understood how one and the same signal causes such different consequences. In the present study, we have studied the effect of activation signals on the outcome of responses to antigen receptor ligation. Two distinct growth-promoting signals were used to activate B cells. Ligation of either RP105, a newly discovered B cell surface molecule, or the CD40 molecule, drove B cells to proliferate. Resultant blastic cells were then exposed to anti-immunoglobulin M (IgM). Blast cells that had been stimulated with anti-RP105 ceased growing and underwent apoptosis after cross-linking of surface IgM. Coligation of the Fc gamma receptor IIB with surface IgM augmented, rather than aborted, this response. In contrast to RP105-activated B cells, blast cells that had been activated by CD40 ligation were unaltered by anti-IgM. On the other hand, CD40-activated B cells became extremely susceptible to Fas-mediated apoptosis, whereas RP105-activated B cells were much less sensitive. Anti-IgM-induced apoptosis in RP105 blasts was independent of Fas, because it was demonstrable with Fas-deficient MRL-lpr/lpr mice. These results demonstrate that the nature of an initial activation signal has a great influence on the fate of activated B cells after (re)engagement of the antigen receptor. RP105, as well as CD40, may be important in this life/death decision.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691124      PMCID: PMC2192673          DOI: 10.1084/jem.184.1.113

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

Review 1.  Transgenic mice and analysis of B-cell tolerance.

Authors:  C C Goodnow
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  B cells from CBA/N mice do not proliferate following ligation of CD40.

Authors:  J Hasbold; G G Klaus
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

Review 3.  Activation-induced apoptosis in lymphocytes.

Authors:  D R Green; D W Scott
Journal:  Curr Opin Immunol       Date:  1994-06       Impact factor: 7.486

Review 4.  Signal transduction by the B cell antigen receptor and its coreceptors.

Authors:  J C Cambier; C M Pleiman; M R Clark
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 5.  The CD40 antigen and its ligand.

Authors:  J Banchereau; F Bazan; D Blanchard; F Brière; J P Galizzi; C van Kooten; Y J Liu; F Rousset; S Saeland
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells.

Authors:  R H Scheuermann; E Racila; T Tucker; E Yefenof; N E Street; E S Vitetta; L J Picker; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

Authors:  J Dhein; H Walczak; C Bäumler; K M Debatin; P H Krammer
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

8.  Effects of the lpr mutation on elimination and inactivation of self-reactive B cells.

Authors:  J C Rathmell; C C Goodnow
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

9.  CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype.

Authors:  L Galibert; N Burdin; B de Saint-Vis; P Garrone; C Van Kooten; J Banchereau; F Rousset
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

10.  Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells.

Authors:  K Miyake; Y Yamashita; Y Hitoshi; K Takatsu; M Kimoto
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Cutting edge: regulation of TLR4-driven B cell proliferation by RP105 is not B cell autonomous.

Authors:  Jessica L Allen; Leah M Flick; Senad Divanovic; Shaun W Jackson; Richard Bram; David J Rawlings; Fred D Finkelman; Christopher L Karp
Journal:  J Immunol       Date:  2012-01-30       Impact factor: 5.422

3.  Targeting Antigens to CD180 but Not CD40 Programs Immature and Mature B Cell Subsets to Become Efficient APCs.

Authors:  Kelsey Roe; Geraldine L Shu; Kevin E Draves; Daniela Giordano; Marion Pepper; Edward A Clark
Journal:  J Immunol       Date:  2019-09-04       Impact factor: 5.422

4.  Expression of CD180, a toll-like receptor homologue, is up-regulated in children with Kawasaki disease.

Authors:  Miyoko Imayoshi; Shuichi Yamamoto; Mamie Watanabe; Shinji Nishimura; Katsuya Tashiro; Masafumi Zaitsu; Hakaru Tasaki; Masao Kimoto; Yuhei Hamasaki; Eiichi Ishii
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

5.  Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.

Authors:  Nino Porakishvili; Ketki Vispute; Andrew J Steele; Nadeeka Rajakaruna; Nina Kulikova; Tamar Tsertsvadze; Amit Nathwani; Rajendra N Damle; Edward A Clark; Kanti R Rai; Nicholas Chiorazzi; Peter M Lydyard
Journal:  Mol Med       Date:  2015-01-14       Impact factor: 6.354

6.  The TLR family protein RP105/MD-1 complex: A new player in obesity and adipose tissue inflammation.

Authors:  Yoshinori Nagai; Yasuharu Watanabe; Kiyoshi Takatsu
Journal:  Adipocyte       Date:  2013-04-01       Impact factor: 4.534

7.  Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions.

Authors:  Sebastian Dütting; Sebastian Brachs; Dirk Mielenz
Journal:  Cell Commun Signal       Date:  2011-01-18       Impact factor: 5.712

Review 8.  RP105-negative B cells in systemic lupus erythematosus.

Authors:  Syuichi Koarada; Yoshifumi Tada
Journal:  Clin Dev Immunol       Date:  2011-09-15

9.  A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: aberrant development and enhanced function of b lymphocytes in ship -/- mice.

Authors:  C D Helgason; C P Kalberer; J E Damen; S M Chappel; N Pineault; G Krystal; R K Humphries
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

10.  The molecular mechanism of B cell activation by toll-like receptor protein RP-105.

Authors:  V W Chan; I Mecklenbräuker; I Su; G Texido; M Leitges; R Carsetti; C A Lowell; K Rajewsky; K Miyake; A Tarakhovsky
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.